Dividend compounder review

TGTX

TG Therapeutics Inc · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score50.00/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 8.5 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 23.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 6.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 12.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$447.2M
Free Cash Flow$-25.0M
FCF Covers DividendUnknown
Debt / Equity1.29
P/E17.3
Revenue Growth 5Y426.7%
Net Margin66.0%
ROE112.6%
Price vs Trend49.2%
3Y Return109.8%
5Y Return24.1%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Free cash flow is negative.
Dividend diary

Activity record

TGTX dividend review warning Warning · Warning

Free cash flow is negative.